Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objective. To study the changes in the intestinal flora and its relationship with nutritional status for patients with cancer pain. Methods. A prospective research method was adopted. One hundred twenty cancer patients with cancer pain were selected as the research objects, who were treated in our hospital from June 2019 to June 2020, and 120 cancer patients without cancer pain were selected as the control group, who were treated in the same period. The differences of the intestinal flora and nutritional status of patients with different severity between the observation group and the control group were compared to analyze the changes of intestinal flora in patients with cancer pain and its correlation with nutritional status. Results. Hemoglobin (HB) ( t = 17.141 , p ≤ 0.001 ), albumin (ALB) ( t = 27.654 , p ≤ 0.001 ), prealbumin (PAB) ( t = 96.192 , p ≤ 0.001 ), and total protein (TP) ( t = 18.781 , p ≤ 0.001 ) in the observation group were significantly lower than those in the control group. There were statistically significant differences in HB ( f = 13.569 , p ≤ 0.001 ), ALB ( f = 22.229 , p ≤ 0.001 ), PAB ( f = 19.521 , p ≤ 0.001 ), and TP ( f = 21.451 , p ≤ 0.001 ) among patients with cancer pain of different severity. Through these two comparisons, their nutritional indicators showed a significant downward trend with the increase in the severity for cancer pain patients; the levels of Lactobacillus ( t = 2.124 , p = 0.035 ), Bifidobacterium ( t = 4.823 , p ≤ 0.001 ), Enterococcus ( t = 3.578 , p ≤ 0.001 ), and Eubacterium ( t = 2.394 , p = 0.017 ) in the observation group were significantly lower than those in the control group. There were statistically significant differences in the levels of Lactobacillus ( f = 20.643 , p ≤ 0.001 ), Bifidobacterium ( f = 19.129 , p ≤ 0.001 ), Enterococcus ( f = 17.408 , p ≤ 0.001 ), and Eubacterium ( f = 22.343 , p ≤ 0.001 ) among patients with cancer pain of different severity. After pairwise comparison, their beneficial intestinal bacteria were significantly lower than those in the control group with the increase in pain in cancer pain patients. Nitric oxide (NO) ( t = 8.418 , p ≤ 0.001 ), galectin-3 ( t = 14.043 , p ≤ 0.001 ), occludin (OCLN) ( t = 47.308 , p ≤ 0.001 ), galectin-1 ( t = 15.298 , p ≤ 0.001 ), zonula occludens protein 1 (ZO-1) ( t = 23.093 , p ≤ 0.001 ), and cingulin ( t = 340.198 , p ≤ 0.001 ) in the observation group were significantly lower than those in the control group. There were statistically significant differences in NO, galectin-3, OCLN, galectin-1, ZO-1, and cingulin for patients with cancer pain of different severity. By comparison, the NO, galectin-3, OCLN, galectin-1, ZO-1, and cingulin of the patients showed a significant downward trend with the aggravation of cancer pain symptoms. Through correlation analysis, the nutritional indicators of patients were positively correlated with intestinal microorganisms and intestinal barrier function. Conclusion. There was a significant correlation between the changes in intestinal flora and nutritional status for patients with cancer pain, which could be used as an important basis for improving the treatment of cancer pain.
Objective. To study the changes in the intestinal flora and its relationship with nutritional status for patients with cancer pain. Methods. A prospective research method was adopted. One hundred twenty cancer patients with cancer pain were selected as the research objects, who were treated in our hospital from June 2019 to June 2020, and 120 cancer patients without cancer pain were selected as the control group, who were treated in the same period. The differences of the intestinal flora and nutritional status of patients with different severity between the observation group and the control group were compared to analyze the changes of intestinal flora in patients with cancer pain and its correlation with nutritional status. Results. Hemoglobin (HB) ( t = 17.141 , p ≤ 0.001 ), albumin (ALB) ( t = 27.654 , p ≤ 0.001 ), prealbumin (PAB) ( t = 96.192 , p ≤ 0.001 ), and total protein (TP) ( t = 18.781 , p ≤ 0.001 ) in the observation group were significantly lower than those in the control group. There were statistically significant differences in HB ( f = 13.569 , p ≤ 0.001 ), ALB ( f = 22.229 , p ≤ 0.001 ), PAB ( f = 19.521 , p ≤ 0.001 ), and TP ( f = 21.451 , p ≤ 0.001 ) among patients with cancer pain of different severity. Through these two comparisons, their nutritional indicators showed a significant downward trend with the increase in the severity for cancer pain patients; the levels of Lactobacillus ( t = 2.124 , p = 0.035 ), Bifidobacterium ( t = 4.823 , p ≤ 0.001 ), Enterococcus ( t = 3.578 , p ≤ 0.001 ), and Eubacterium ( t = 2.394 , p = 0.017 ) in the observation group were significantly lower than those in the control group. There were statistically significant differences in the levels of Lactobacillus ( f = 20.643 , p ≤ 0.001 ), Bifidobacterium ( f = 19.129 , p ≤ 0.001 ), Enterococcus ( f = 17.408 , p ≤ 0.001 ), and Eubacterium ( f = 22.343 , p ≤ 0.001 ) among patients with cancer pain of different severity. After pairwise comparison, their beneficial intestinal bacteria were significantly lower than those in the control group with the increase in pain in cancer pain patients. Nitric oxide (NO) ( t = 8.418 , p ≤ 0.001 ), galectin-3 ( t = 14.043 , p ≤ 0.001 ), occludin (OCLN) ( t = 47.308 , p ≤ 0.001 ), galectin-1 ( t = 15.298 , p ≤ 0.001 ), zonula occludens protein 1 (ZO-1) ( t = 23.093 , p ≤ 0.001 ), and cingulin ( t = 340.198 , p ≤ 0.001 ) in the observation group were significantly lower than those in the control group. There were statistically significant differences in NO, galectin-3, OCLN, galectin-1, ZO-1, and cingulin for patients with cancer pain of different severity. By comparison, the NO, galectin-3, OCLN, galectin-1, ZO-1, and cingulin of the patients showed a significant downward trend with the aggravation of cancer pain symptoms. Through correlation analysis, the nutritional indicators of patients were positively correlated with intestinal microorganisms and intestinal barrier function. Conclusion. There was a significant correlation between the changes in intestinal flora and nutritional status for patients with cancer pain, which could be used as an important basis for improving the treatment of cancer pain.
Introduction: The diagnosis of cancer causes several changes in the lives of human beings, generating impacts on the emotional, physical and psychological state. Fear, stress and sadness usually interfere in quality of life, so dance therapy is a therapeutic method that will serve as an instrument for health rehabilitation, using dance as a means to achieve functional balance and self-esteem of people diagnosed with cancer. Objective: To describe the effectiveness and benefits of dance therapy, in order to emphasize complementary therapies that are important methods during treatment. Material and Methods: Systematic review, in which articles were selected between 2018 and 2021. Published in both Portuguese and English languages in the electronic database as Latin American Caribbean Literature in Sciences of Health (Lilacs), Pubmed, Scientific Electronic Library Online (Scielo) and Physiotherapy Evidence Database (PEDro). Results: The search for data was summarized in a flowchart, in which 546 articles were found based on the combination of descriptors in health science, but after reading, 8 scientific articles were selected divided into three categorical themes; psychological and social. Conclusion: Dance therapy provides physical, psychosocial benefits directly in functional capacity and quality of life during choreography and musical rhythms, influencing functional capacity, self-image, acceptance and especially quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.